FDA
approval
· 2022-08-02
FDA Approved: RILUZOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
The FDA approved a supplemental application for riluzole submitted by Glenmark Pharmaceuticals Inc., USA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RILUZOLE (RILUZOLE)